F2G inks $100M Se­ries H for an­oth­er shot at treat­ing fun­gal in­fec­tions

Man­ches­ter, UK-based F2G has patched to­geth­er an­oth­er $100 mil­lion in fund­ing a lit­tle over a year af­ter re­ceiv­ing a CRL for its ex­per­i­men­tal fun­gal in­fec­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA